Form 4: VolitionRx CEO Butera Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Salvatore Thomas Butera disposed of 5,230 shares of VolitionRx common stock on September 28, 2024, to cover tax obligations related to the settlement of restricted stock units.
Summary
- On September 28, 2024, Salvatore Thomas Butera, CEO of Volition Veterinary and an officer of VolitionRx Ltd, disposed of 5,230 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations upon the settlement of 19,125 restricted stock units.
- The shares were retained by VolitionRx for cancellation, and no shares were sold by Butera or VolitionRx.
- The price per share for the transaction was $0.578.
- Following the transaction, Butera directly owns 282,553 shares of common stock and jointly owns 99,350 shares with his spouse.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily reflect a change in the CEO's confidence in the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a transaction related to tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of transaction where Salvatore Thomas Butera disposed of shares to cover tax obligations. |
| 10/01/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.